Association between immune-related adverse events (irAEs) and disease control or overall survival in patients (pts) with advanced melanoma treated with 10 mg/kg ipilimumab in three phase II clinical trials Meeting Abstract
| Authors: | Lutzky, J.; Wolchok, J.; Hamid, O.; Lebbe, C.; Pehamberger, H.; Linette, G.; de Pril, V.; Ibrahim, R.; Hoos, A.; O'Day, S. |
| Abstract Title: | Association between immune-related adverse events (irAEs) and disease control or overall survival in patients (pts) with advanced melanoma treated with 10 mg/kg ipilimumab in three phase II clinical trials |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 469s |
| Language: | English |
| ACCESSION: | WOS:000276606606050 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.9034 |
| Notes: | Meeting Abstract: 9034 -- Source: Wos |
